| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |